Back
Axsome Therapeutics Stock Price Chart
Sell
37
AXSM
Axsome Therapeutics
Last Price:
44.94
Seasonality Move:
51.44%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
Axsome Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.92 | Sell |
| 20-day SMA: | 58.37 | Sell |
| 50-day SMA: | 51.77 | Sell |
| 200-day SMA: | 37.39 | Buy |
| 8-day EMA: | 51.57 | Sell |
| 20-day EMA: | 55.26 | Sell |
| 50-day EMA: | 52 | Sell |
| 200-day EMA: | 42.49 | Buy |
Axsome Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.48 | Sell |
| Relative Strength Index (14 RSI): | 30.84 | Sell |
| Chaikin Money Flow: | -790333 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.9 - 66.22) | Sell |
| Bollinger Bands (100): | (27.63 - 55.21) | Buy |
Axsome Therapeutics Technical Analysis
| Sep-14 | Sep-15 | Sep-16 | Sep-19 | Sep-20 | Sep-21 | Sep-22 | Sep-23 | Sep-26 | Sep-27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
- Axsome Therapeutics share price is 44.94 while AXSM 8-day simple moving average is 52.92, which is a Sell signal.
- The stock price of AXSM is 44.94 while Axsome Therapeutics 20-day SMA is 58.37, which makes it a Sell.
- Axsome Therapeutics 50-day simple moving average is 51.77 while AXSM share price is 44.94, making it a Sell technically.
- AXSM stock price is 44.94 and Axsome Therapeutics 200-day simple moving average is 37.39, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
37
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a Sell
The current Axsome Therapeutics [AXSM] share price is $44.94. The Score for AXSM is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
1.81B
Price in USD:
44.94
Share Volume:
1.14M
Axsome Therapeutics 52-Week Range
52-Week High:
71.98
52-Week Low:
20.63
Sell
37
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?
The Axsome Therapeutics stock price is 44.94 USD today. -
Will AXSM stock go up or go down?
Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Axsome Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
- Axsome Therapeutics share price is 44.94 while AXSM 8-day exponential moving average is 51.57, which is a Sell signal.
- The stock price of AXSM is 44.94 while Axsome Therapeutics 20-day EMA is 55.26, which makes it a Sell.
- Axsome Therapeutics 50-day exponential moving average is 52.00 while AXSM share price is 44.94, making it a Sell technically.
- AXSM stock price is 44.94 and Axsome Therapeutics 200-day simple moving average is 42.49, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.81 per share, and an increase next year of $1.90 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
- AXSM Moving Average Covergence Divergence (MACD) indicator is -1.48, suggesting Axsome Therapeutics is a Sell
- Axsome Therapeutics Relative Strength Index (RSI) is 30.84, which suggest Axsome Therapeutics is oversold
- The Bollinger Bands (25) for Axsome Therapeutics is (53.9 - 66.22), which suggest Axsome Therapeutics is a Buy
- The Bollinger Bands (100) for Axsome Therapeutics is (27.63 - 55.21), which suggest Axsome Therapeutics is a Buy
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.